EP1779859 - Bibliographic data
Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells
| Last update | 30/05/2025 |
|---|---|
| Legal status | Brevet déchu |
| Origin | Européen |
| (73) Holder |
CYCLACEL PHARMACEUTICALS, INC. 200 Connell Drive
Berkeley Heights, NJ 07922
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Soren Skov Blegdamsvej 3, Building 22-5, University of Copenhagen
2200 Copenhagen North
Allemagne
|
| (74) Agent |
Mail recipient CRIPPS, JOANNA ELIZABETH ET AL Mewburn Ellis LLP 33 Gutter Lane
WC2B 6HP
LONDON
Royaume-Uni
|
| (21) Request number | EP07002930.1 |
|---|---|
| (22) Request date | 06/12/2000 |
| (11) Publication number | EP1779859 |
|---|---|
| Publication date | 09/06/2010 |
| (54) Title of the invention | Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells |
|---|---|
| (51) International classification | A61K 38/15 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 169731 P
(31) Number: 193582 P |
|---|---|
| Initial application | None |
| Divisional application | None |
| Expected annuity |
Annuity: 11 -
Amount: 165 € -
Due date 31/12/2010
Surtax: 11 - Amount: 33 € - Due date 01/07/2011 |
|---|---|
| Last annuity | None |
| Publication | BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2010/2, of 30/06/2010 |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 09/06/2010 Déchéance du brevet d'invention après période de grâce - Legal date 31/12/2010 Entrée en période de grâce du brevet d'invention - Legal date 31/12/2010 |